Zevra Therapeutics, Inc. (ZVRA) Net margin 2019–2025
Zevra Therapeutics, Inc. (ZVRA) net profit margin by fiscal year — reported net income divided by reported revenue.
78.2%FY2025 · since FY2019: -191.0% → 78.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 78.2% | +525.0 pp |
| FY2024 | -446.9% | -279.2 pp |
| FY2023 | -167.7% | +95.8 pp |
| FY2022 | -263.5% | -233.6 pp |
| FY2021 | -29.9% | +66.2 pp |
| FY2020 | -96.0% | +95.0 pp |
| FY2019 | -191.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice